title: Eosinophilic inflammation in COPD: prevalence and clinical characteristics.
authors.affiliation: University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK.
authors.forename: Dave
authors.initials: D
authors.lastname: Singh
authors.affiliation: University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Manchester, UK ukolsum@meu.org.uk.
authors.forename: Umme
authors.initials: U
authors.lastname: Kolsum
authors.affiliation: Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
authors.forename: Chris E
authors.initials: CE
authors.lastname: Brightling
authors.affiliation: GlaxoSmithKline, Research and Development, Research Triangle Park, NC, USA.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Locantore
authors.affiliation: Fundació Investigació Sanitària Illes Balears (FISIB), Centro de investigación biomedical en red de enfermedades respiratorias (CIBERES), Palma de Mallorca, Spain.
authors.forename: Alvar
authors.initials: A
authors.lastname: Agusti
authors.affiliation: GlaxoSmithKline, Research and Development, King of Prussia, PA, USA.
authors.forename: Ruth
authors.initials: R
authors.lastname: Tal-Singer
mesh_terms: D000328:Adult; D000368:Aged; D015331:Cohort Studies; D004802:Eosinophilia / Q000453:epidemiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007249:Inflammation / Q000453:epidemiology* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology* / Q000276:immunology